We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+12.09%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$683M
AUM Growth
-$101M
Cap. Flow
-$82.5M
Cap. Flow %
-12.08%
Top 10 Hldgs %
52.33%
Holding
153
New
26
Increased
35
Reduced
53
Closed
35

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$20M
2
BIIB icon
Biogen
BIIB
+$11.2M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.32M
4
ORA icon
Ormat Technologies
ORA
+$5.09M
5
OPK icon
Opko Health
OPK
+$5.01M

Top Sells

Rank Stock Value
1
ESLT icon
Elbit Systems
ESLT
+$29.2M
2
SHPG
Shire pic
SHPG
+$27M
3
AGN
Allergan plc
AGN
+$23M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$12.7M
5
VTRS icon
Viatris
VTRS
+$9.62M

Sector Composition

Rank Sector Weight
1 Healthcare 60.65%
2 Utilities 5.79%
3 Technology 1.86%
4 Consumer Discretionary 1.38%
5 Communication Services 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$81.5M 11.94%
400,000
+397,549
+16,220% +$81.6M
TEVA icon
2
Teva Pharmaceuticals
TEVA
$40.8B
$51.5M 7.54%
784,850
+31,945
+4% +$1.97M
ORA icon
3
Ormat Technologies
ORA
$6B
$38.7M 5.67%
272,462
+139,803
+105% +$5.09M
PFE icon
4
Pfizer
PFE
$143B
$38M 5.56%
1,240,149
+635,139
+105% +$20M
BIIB icon
5
Biogen
BIIB
$30B
$37.9M 5.56%
123,850
+38,850
+46% +$11.2M
AGN
6
DELISTED
Allergan plc
AGN
$31.3M 4.58%
100,000
-77,100
-44% -$23M
XNTK icon
7
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.06B
$23.2M 3.39%
329,800
+323,800
+5,397% +$17.5M
ABBV icon
8
AbbVie
ABBV
$443B
$21.4M 3.14%
362,000
+35,000
+11% +$2.02M
CELG
9
DELISTED
Celgene Corp
CELG
$17.6M 2.58%
147,200
+27,200
+23% +$3.15M
VTRS icon
10
CALL
Viatris
VTRS
$20.4B
$16.2M 2.38%
300,000
+297,000
+9,900% +$14.3M
GILD icon
11
Gilead Sciences
GILD
$162B
$14.4M 2.11%
142,700
+22,700
+19% +$2.36M
ALXN
12
DELISTED
Alexion Pharmaceuticals
ALXN
$11.3M 1.65%
59,164
+24,164
+69% +$4.22M
BMY icon
13
Bristol-Myers Squibb
BMY
$133B
$8.36M 1.22%
121,500
-28,500
-19% -$1.88M
SHPG
14
DELISTED
Shire pic
SHPG
$8.2M 1.2%
40,000
-129,751
-76% -$27M
ACOR
15
DELISTED
Acorda Therapeutics
ACOR
$6.12M 0.9%
1,192
-1,058
-47% -$4.62M
VRTX icon
16
Vertex Pharmaceuticals
VRTX
$121B
$6.09M 0.89%
48,400
+8,400
+21% +$1.01M
FPRX
17
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$6.02M 0.88%
145,000
-30,000
-17% -$1.01M
GOOG icon
18
Alphabet (Google) Class C
GOOG
$4.36T
$5.76M 0.84%
+148,180
New +$5.32M
INCY icon
19
Incyte
INCY
$24.2B
$5.6M 0.82%
51,621
-48,379
-48% -$5.4M
SAGE
20
DELISTED
Sage Therapeutics
SAGE
$5.42M 0.79%
93,000
+85,000
+1,063% +$4.21M
CEL
21
DELISTED
Cellcom Israel, Ltd.
CEL
$5.14M 0.75%
212,300
-145,152
-41% -$1.01M
IONS icon
22
Ionis Pharmaceuticals
IONS
$8.6B
$5.03M 0.74%
81,200
+13,200
+19% +$712K
OPK icon
23
Opko Health
OPK
$985M
$5.03M 0.74%
+500,000
New +$5.01M
MGNX icon
24
MacroGenics
MGNX
$235M
$4.74M 0.69%
153,000
-17,000
-10% -$516K
BLCM
25
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$4.69M 0.69%
23,152
+1
+0% +$179
1
2 3 4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q4 2015 Portfolio in Review

As of Q4 2015, Sphera Funds Management held 153 positions worth $683M, down 13% from $784M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Sphera Funds Management withdrew a net $82.5M in Q4 2015, closing 35 positions and reducing 53 holdings. Its most notable exit was Elbit Systems, an estimated $29.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 56% a quarter earlier, followed by Utilities and Technology.

Against the trend, Sphera Funds Management opened a new position in Alphabet (Google) Class C worth $5.76M.

  • Sphera Funds Management's largest Q4 2015 buy was Alphabet (Google) Class C: 148,180 shares worth $5.76M.
  • Sphera Funds Management added most to Pfizer in Q4 2015, an estimated $20M increase.
  • Sphera Funds Management's biggest Q4 2015 reduction was Shire pic, cutting an estimated $27M.
  • Sphera Funds Management fully exited Elbit Systems in Q4 2015, selling an estimated $29.2M.
  • Sphera Funds Management's ten largest holdings make up 52% of its $683M portfolio in Q4 2015.
  • Sphera Funds Management opened 26 new positions and closed 35 in Q4 2015.
  • Sphera Funds Management's portfolio value fell 13% quarter-over-quarter to $683M.

Based on Sphera Funds Management's 13F filing for Q4 2015, filed 11 Feb 2016.